UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study

Diabetes, obesity & metabolism, 2024-10, Vol.26 (10), p.4583-4590

2024

Volltextzugriff (PDF)

The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

Diabetes, obesity & metabolism, 2024-01, Vol.26 (1), p.385-388

2024

Volltextzugriff (PDF)

Uric acid predicts long‐term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study

Diabetes, obesity & metabolism, 2020-08, Vol.22 (8), p.1388-1396

2020

Volltextzugriff (PDF)

Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review

Archives of Endocrinology and Metabolism, 2017-03, Vol.61 (2), p.198-201

2017

Volltextzugriff (PDF)

Fenofibrate Induces a Resolving Profile in Heart Macrophage Subsets and Attenuates Acute Chagas Myocarditis

ACS infectious diseases, 2024-05, Vol.10 (5), p.1793-1807

2024

Volltextzugriff (PDF)

Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study

Journal of Atherosclerosis and Thrombosis, 2017/01/01, Vol.24(1), pp.77-94

2017

Volltextzugriff (PDF)

Complicated Treatment Course of Severe Asymptomatic Hypertriglyceridemia: A Case Report and Literature Review

The American journal of case reports, 2024-04, Vol.25, p.e943858-e943858

2024

Volltextzugriff (PDF)

Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011-08, Vol.11 (4), p.227-247

Keating, Gillian M.

2011

Volltextzugriff (PDF)

Macrophages Mediate Healing Properties of Fenofibrate in Experimental Chagasic Cardiomyopathy

ACS infectious diseases, 2023-02, Vol.9 (2), p.213-220

2023

Volltextzugriff (PDF)

Combination statin-fibrate therapy: safety aspects

Diabetes, obesity & metabolism, 2009-02, Vol.11 (2), p.89-94

2009

Volltextzugriff (PDF)

PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia

Medical science monitor, 2016-03, Vol.22, p.743-751

2016

Volltextzugriff (PDF)

Fish Oil for the Treatment of Cardiovascular Disease

Cardiology in review, 2010-09, Vol.18 (5), p.258-263

2010

Volltextzugriff (PDF)

The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes

Journal of Atherosclerosis and Thrombosis, 2017/07/01, Vol.24(7), pp.735-748

2017

Volltextzugriff (PDF)

Fenofibrate and Impaired Taste Perception in Type 2 Diabetes

The American journal of case reports, 2020-11, Vol.21, p.e927647-e927647

Davis, Timothy M E

2020

Volltextzugriff (PDF)

Anti-Obesity Effect of Fish Oil and Fish Oil-Fenofibrate Combination in Female KK Mice

Journal of Atherosclerosis and Thrombosis, 2009, Vol.16(5), pp.674-683

2009

Volltextzugriff (PDF)

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010-01, Vol.10 (2), p.73-84

2010

Volltextzugriff (PDF)

Efficacy and Safety of Alternate Day Therapy With Atorvastatin and Fenofibrate Combination in Mixed Dyslipidemia: A Randomized Controlled Trial

Journal of cardiovascular pharmacology and therapeutics, 2014-05, Vol.19 (3), p.296-303

2014

Volltextzugriff (PDF)

Fenofibrate: metabolic and pleiotropic effects

Current vascular pharmacology, 2005-01, Vol.3 (1), p.87-98

2005

Volltextzugriff (PDF)

Effect of Rosuvastatin Monotherapy and in Combination With Fenofibrate or Omega-3 Fatty Acids on Serum Vitamin D Levels

Journal of cardiovascular pharmacology and therapeutics, 2012-12, Vol.17 (4), p.382-386

2012

Volltextzugriff (PDF)

The Effects of Statin and Fibrate on Lowering Small Dense LDL- Cholesterol in Hyperlipidemic Patients with Type 2 Diabetes

Journal of Atherosclerosis and Thrombosis, 2007, Vol.14(3), pp.128-132

2007

Volltextzugriff (PDF)

Fenofibrate, homocysteine and renal function

Current vascular pharmacology, 2010-09, Vol.8 (5), p.589-603

2010

Volltextzugriff (PDF)

Normalization of metabolic syndrome using fenofibrate, metformin or their combination

Diabetes, obesity & metabolism, 2007-11, Vol.9 (6), p.869-878

2007

Volltextzugriff (PDF)

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005, Vol.5 (6), p.379-387

Nesto, Richard W

2005

Volltextzugriff (PDF)

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

World journal of gastroenterology : WJG, 2004-03, Vol.10 (6), p.894

2004

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(58)

Publikationsform

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Fenofibrate - Therapeutic Use
(113)
Humans
(113)
Hypolipidemic Agents - Therapeutic Use
(67)
Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Male
(61)
Female
(59)
Middle Aged
(51)
Fenofibrate
(45)
Adult
(36)
Aged
(35)
Fenofibrate - Adverse Effects
(31)
Triglycerides - Blood
(28)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(22)
Hypertriglyceridemia - Drug Therapy
(22)
Drug Therapy, Combination
(21)
Fenofibrate - Pharmacology
(21)
Hyperlipidemias - Drug Therapy
(21)
Pharmacology & Pharmacy
(21)
Animals
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study

The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

Uric acid predicts long‐term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study

Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review

Fenofibrate Induces a Resolving Profile in Heart Macrophage Subsets and Attenuates Acute Chagas Myocarditis

Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study

Complicated Treatment Course of Severe Asymptomatic Hypertriglyceridemia: A Case Report and Literature Review

Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus

Macrophages Mediate Healing Properties of Fenofibrate in Experimental Chagasic Cardiomyopathy

Combination statin-fibrate therapy: safety aspects

PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia

Fish Oil for the Treatment of Cardiovascular Disease

The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes

Fenofibrate and Impaired Taste Perception in Type 2 Diabetes

Anti-Obesity Effect of Fish Oil and Fish Oil-Fenofibrate Combination in Female KK Mice

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

Efficacy and Safety of Alternate Day Therapy With Atorvastatin and Fenofibrate Combination in Mixed Dyslipidemia: A Randomized Controlled Trial

Fenofibrate: metabolic and pleiotropic effects

Effect of Rosuvastatin Monotherapy and in Combination With Fenofibrate or Omega-3 Fatty Acids on Serum Vitamin D Levels

The Effects of Statin and Fibrate on Lowering Small Dense LDL- Cholesterol in Hyperlipidemic Patients with Type 2 Diabetes

Fenofibrate, homocysteine and renal function

Normalization of metabolic syndrome using fenofibrate, metformin or their combination

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy

Aktive Filter

Suchergebnisse filtern